Aggressive Periodontitis by Alpan, Aysan Lektemur
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 6
Aggressive Periodontitis
Aysan Lektemur Alpan
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.76878
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
ys  L t r  l
Additional infor ation is available at the end of the chapter
Abstract
Aggressive periodontitis (AgP) is a disease characterized by rapid loss of periodontal tis-
sues affecting systemically healthy individuals under age of 30 years. AgP classified into 
two categories named localized and generalized aggressive periodontitis. It differs from 
chronic periodontitis (CP) depending on age of onset of the disease, rate of progression of 
the disease, structure and composition of the associated subgingival microflora, changes 
in host response and familial predisposition. Tissue destruction in patients with AgP is 
not directly related to bacterial deposits also personal immune response plays a major 
role in severity of destruction. Surgical and non-surgical techniques can be applied in the 
treatment of AgP. It is important to treat and obtain frequent controls of individuals with 
AgP. The main purpose of the treatment is to create a clinical condition that can hold the 
largest number of teeth in the mouth. After the treatment performed and provided the 
health of periodontal tissues, patient should be included in the maintenance program.
Keywords: aggressive periodontitis, generalized aggressive periodontitis, genetics, 
familial predisposition, localized aggressive periodontitis
1. Introduction
Aggressive periodontitis (AgP) is a disease characterized by rapid loss of periodontal tissues 
affecting systemically healthy individuals during adolescence and adulthood, and forms a 
group of periodontal diseases [1]. It differs from chronic periodontitis (CP) depending on 
age of onset of the disease, rate of progression of the disease, structure and composition of 
the associated subgingival microflora, changes in host response and familial predisposition.
AgP classified into two categories named localized and generalized aggressive periodontitis 
[2] and took place prepubertal, juvenile, rapidly progressive periodontitis in the group that 
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was defined as early onset periodontitis in 1999 International Workshop for a Classification 
of Periodontal Disease and Conditions [1]. This report defined some characteristic features of 
the AgP [2, 3].
• Patients are clinically healthy, except for the presence of periodontitis.
• Rapid attachment loss and bone destruction.
• Familial aggregation.
Secondary features that are often, but not always, present include the following:
• The amounts of microbial deposits are inconsistent with the severity of periodontal tissue 
destruction.
• Elevated proportions of Actinobacillus actinomycetemcomitans (A. actinomycetemcomitans) 
which is now termed Aggregatibacter actinomycetemcomitans.
• Elevated proportions of Porphyromonas gingivalis (P. gingivalis) in some populations.
• Phagocyte abnormalities.
• A hyper-responsive macrophage phenotype, including elevated levels of prostaglandin E2 
and interleukin-1β.
2. Localized aggressive periodontitis (LAgP)
2.1. Clinical features
LAgP starts at a much earlier age than CP, but it is not right to go to a certain age limit. The 
age of onset of the disease can help us diagnose the disease [4]. There is no significant sub-
gingival and supragingival calculus in patients with LAgP. Lesions are mostly associated 
with the biofilm layer. In the form of LAgP there is little or no inflammation of the gums 
[5, 6]. During this period gingival hyperplasia depending on dental plaque and/or calculus 
rarely appears [6]. It is characterized by rapid bone loss in the first molar and incisors [7]. 
In this disease, there are at least two permanent teeth involvement, one of them must be the 
first molar, and involving no more than two teeth other than first molars and incisors [8]. 
Powerful serum antibody response to infecting agents and circumpubertal onset are among 
disease features [3]. According to the workshop in 1999, if the involvement is less than 30%, 
the disease is localized, if it is not, considered as generalize [1]. During the disease bone 
loss in the first molar region is symmetric [9]. Patients with LAgP between the ages of 21–35 
are those who have not been diagnosed and treated before, depending on the severity of 
the disease and previous treatments, tooth loss, bone defects and gingival recessions are 
observed [6, 7].
The following reasons have been proposed regarding the limited localization of lesions in 
AgP [8].
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1. A. actinomycetemcomitans affects the host response in many ways after colonization in first 
molars and incisors:
• A actinomycetemcomitans secretes a factor that inhibits Polymorphonuclear leukocytes 
(PMNL) chemotaxis.
• A actinomycetemcomitans secretes some factors such as endotoxin, collagenase and leu-
kotoxin to facilitate the colonization of bacteria in the periodontal pocket and cause 
destruction of periodontal tissues.
2. Antagonistic bacteria against to A. actinomycetemcomitans. Colonize the periodontal tissues 
and prevent the colonization of A. actinomycetemcomitans in other areas of the mouth. This 
situation leads the localization of infection and tissue destruction.
3. For unknown reasons, A. actinomycetemcomitans may lose its ability to produce leuko-
toxin. In this case, the disease progression slows down and colonization of new areas is 
prevented.
Figure 1. LAgP patient; (a)-clinical view of the LAgP patient, (b) 7 mm probing depth at distal of the incisor tooth, (c) radiographic 
view of the LAgP patient.
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4. The possibility that the cement formation is defective and may also cause the lesions to 
be localized. The hypoplasia or aplastic cement formation was seen in the examinations 
performed on teeth withdrawn from patients with LAgP.
LAgP progresses rapidly and bone loss is three to four times greater than CP. Other clini-
cal features of LAgP are distolabial migrations of the upper incisor teeth and consequent 
diestema formation, increased mobility in the first molars, tenderness on the uncovered root 
surfaces, deep pain spreading in every direction during chewing that does not last so long. In 
this phase, periodontal abscess and regional lymphadenopathy may occur [8].
2.2. Radiographic features
The classic feature of LAgP is the vertical bone loss seen in alveolar bone in the first molar and 
incisor teeth in healthy teenagers. Radiographic finding may include an arc shaped alveolar 
bone loss extending from the distal surface of the premolar to the mesial surface of the second 
molar. In this disease bone loss usually wider than CP [8] (Figure 1).
3. Generalized aggressive periodontitis (GAgP)
3.1. Clinical features
GAgP; is characterized by diffuse attachment and bone loss affecting at least three perma-
nent teeth other than first molar and incisor teeth, usually seen in young adults, where poor 
serum antibody responses to infectious agents occur [10]. The GAgP may begin as localized 
and become more generalized as more teeth are affected over time. The disease remained 
active and passive periods. The rate of attachment and bone loss is not the same at these 
times. Dark red and ulcerated areas are characterized by severe acute inflammatory disease 
table is detected during the active phase. The condition is accompanied by bleeding which 
usually occurs with light stimulation and discharge of the pus. Severe attachment and bone 
loss occur during this period of the disease [10, 11]. GAgP sometimes accompanied by 
systemic findings such as weight loss, mental depression and fatigue [12]. Also, GAgP has 
been implicated in the pathogenesis of systemic diseases such as uncontrolled diabetes mel-
litus, AIDS, leukemia, neutropenia, histiocytosis X, syndromes such as Papillon-Lefevre or 
Cheidak-Higashi, rare inherited diseases such as hypophosphatasia and intraoral symp-
tom of acquired disorders such as granulocytopenia [13]. In the passive period, the clinical 
image is especially similar to that of healthy individuals in terms of color, shape and con-
sistency. However, deep periodontal pockets are encountered in the probing. It has been 
stated that Gram(−) microorganisms play a role mostly in microbial dental plaque (MDP). 
Pathogenic microorganisms, especially P. gingivalis and Tannerella forsythensis (T. forsythensis) 
are related to disease progression [10, 11]. Patients also had increased antibody response 
against A. Actinomycetemcomitans, Prevotella intermedia (P. intermedia) and Campylobacter rectus 
(C. rectus) [14].
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3.2. Radiographic features
The radiographic image of GAgP, characterized by severe horizontal and vertical alveolar 
bone loss especially in the first molar and incisors. This severe destruction can affect only a 
few teeth as well as the majority of the teeth in the mouth. The disease can progress so quickly 
that the aggressive nature, radiographs taken at different times, bone loss is easily recogniz-
able [8]. Page et al. [12] reported that in patients with GAgP, the loss of alveolar bone in 
regions where periodontal destruction is more severe is increased from 25–60% over 9 weeks 
(Figure 2).
4. Epidemiology of AgP
The prevalence of AgP changes significantly different between geographical regions and 
between different racial/ethnic origins. For this reason, the prevalence of the disease in a 
given population can be determined by the distribution of the population according to the 
type and proportion of the race and ethnic group. In the studies, the methods which have 
been used to diagnosis of disease such as; whether radiographies is taken or not, differences 
in diagnostic equipment, different indexing systems etc. varies. According an epidemiologic 
Figure 2. GAgP patient; (a) clinical view of the GAgP patient, (b, c) increased probing depth around the teeth, (d) radiographic 
view of the GAgP patient.
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study performed by Susin et al. [15] prevalence of AgP in Africa is between 1–5%, in North 
and mid-Europe Caucasians 0.1%, in South European ~0.5%, in North America ~0.1–0.2% of 
Caucasians, 0.5–1.0% of Hispanics and 2.6% of Black people, in South America 0.3–2.0%, in 
Asia 0.2–1.0%. According these results, AgP can be a health problem in some populations 
and/or races. In a national survey which include US school children aged 13–19 years, the 
prevalence of AgP was found 0.40% in 13–15 years, 0.80% in 16–19 years, 0.06% in whites, 
2.60% in blacks and 0.50% in Hispanics [16]. Haubek et al. [17] found a high prevalence of 
AgP as 7.6% in Moroccan children aged 14–19 years. Also Albandar et al. [18] found AgP with 
a high prevalence 6.5%, in Uganda. Given the prevalence of AgP in Asia; it found 1.8% in 
Iraq, 0.86% in Israel, 0.47% in Japan and 0.42% in Saudi Arabia [19]. In South America, the 
prevalence of disease was vary among the countries: 0.32–2.6% in Brazil, 0.32% in Chile [19]. 
In Europe it has relatively low prevalence been observed; 0.1% in Denmark, 0.1% in Finland, 
0.5% in Italy, 0.1–0.3% in Netherlands, 0% in Norway, 0.11–0.13% in Switzerland, 0.02–0.8% in 
United Kingdom [19]. The disease is most commonly seen in African-Caribbean (80%) and 
least Norwegian (0.2%) [20]. In terms of the prevalence of racial attachment, it was found 
that AgP was higher in black people (2.6%) than white people (0.17%) [21]. Most studies 
show comparable disease prevalence in both male and female patients. Gender factor and 
its role in development of AgP have not become clear. In some studies AgP was found to 
be more common in women than men with 3: 1 ratio [22–25]. However, researches are also 
available that indicates AgP more common in men than women [18, 21].
5. Pathogenesis of AgP
Periodontal destruction in AgP occurs pathogenic microorganisms and host immune system 
interaction [14, 26] and this interaction is influenced by many local and systemic factors [27]. 
Four basic factors play role in the pathogenesis of AgP [26].
• Microbial factors.
• Host factors.
• Environmental factors.
• Genetic factors.
5.1. Microbial factors
The presence of microorganisms is essential for the initiation of the inflammatory process in 
periodontal diseases and the factors related to the host are involved in the progress of the 
disease. The appearance of severe tissue destruction with a small amount of plaque in AgP 
suggests that microorganisms with high virulence in the etiology of the disease may play a 
role. A. actinomycetemcomitans is considered to be the most effective etiologic agent in AgP 
for about 30 years [28]. A. actinomycetemcomitans, short (0.4–1 μm), facultative anaerobic, 
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immobile, Gram(−) rod. The virulence factor is serotypically variable and some serotypes are 
known to be invasive epithelial cells and gingival tissue. Tonetti and Mombelli (1999) listed 
the findings of A. actinomycetemcomitans in relation to LAgP [11].
1. In areas where periodontal tissue destruction occurs in aggressive periodontitis patients, 
90% of A. actinomycetemcomitans are found.
2. In the areas where the destruction proceeds and continues, in high amounts, A. actinomy-
cetemcomitans were detected.
3. High serum antibody levels against A. actinomycetemcomitans were observed in the major-
ity of locally aggressive periodontitis patients.
4. Clinical trials have shown that improvement in clinical parameters with treatment is as-
sociated with a decrease in the level of A. actinomycetemcomitans in subgingival floras.
5. It is known that A. actinomycetemcomitans has virulence factors that can play a role in the 
development of the disease such as leukotoxin.
A. actinomycetemcomitans has been suggested to play a role in the onset of AgP by interacting 
with facultative anaerobic and capnophilic species such as the locally useful Capnocytophaga 
species and Eikenella corrodens (E. corrodens) [29]. Today, the microbiological profile of AgP 
has changed from the presence of specific microorganisms to the presence of more com-
plex microbiota [30]. Some of the bacteria found in periodontal pockets related to gingivi-
tis, while some are related to periodontitis. Dental plaque biofilm is a dynamic structure and 
changes over time. Different bacterial groups are complexed at different times in biofilm. 
Among these, orange complex bacteria: P. intermedia, Prevotella nigrescense (P. nigrescense), 
Parvimonas micra (P. micra), Fusobacterium nucleatum (F. nucleatum), C. rectus, Eubacterium noda-
tum (E. nodatum) and Campylobacter showae (C. showae) build a bridge between the pathogens 
seen in the early period of periodontal disease named red complex bacteria. Red complex 
bacteria named P. gingivalis, T. forsythia and Treponema denticola (T. denticola) were associated 
with periodontal tissue destruction [31]. In some studies, P. gingivalis and T. Forsythia have 
been shown to be an etiological agent for AgP [10, 11]. Patients also had increased antibody 
response against A. Actinomycetemcomitans, P. intermedia and C. rectus [14]. Electron micro-
scopic studies performed on LAgP demonstrates that bacteria found in the connective tissue 
to the extending bone surface. When examined by more advanced techniques, the presence 
of A. Actinomycetemcomitans, Capnocytophaga sputigena (C. sputigena), mycoplasma strains and 
spirochetes has been defined [8]. In the extracted teeth affected by LAgP, electron microscopic 
observations showed that in the biofilm layer on the root surface formed Gram(−) cocci bacteria 
and other microorganisms [5]. In some studies, it has been reported that spirochetes are rarely 
or not present in LAgP lesions [32, 33], in contrast some authors reported that there is a high 
number of spirochetes in lesions [34, 35]. In a study performed in population of Chilean patients 
with GAgP and CP, P. gingivalis, P. micra and C. rectus isolated from subgingival plaque and 
found to be related to disease progression [36]. In a recent study performed with patients who 
affected by GAgP, the authors concluded that existence of a complex cooperative interaction 
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promoted by Herpes Simplex Virus Type-1 (HSV-1) infection, involving Staphylococcus aureus 
(S. aureus) and the periodontopathogens P. gingivalis, T. forsythia, and Fusobacterium periodon-
ticum (F. periodonticum), that could promote an accelerate progression of lesions of GAgP [37]. 
Dogan et al. [38] compared subgingival flora in LAgP, GAgP, CP and healthy controls in 69 
Turkish people. T. forsythensis and C. rectus found the lowest frequency in LAgP. A. actinomy-
cetemcomitans, P. gingivalis, and C. rectus were higher in GAgP than in healthy controls. Yeasts 
also were found in samples. Lee et al. [39] found the bacteria in diseased sites in Korean AgP 
patients, descending percentages; Fusobacterium sp., P. gingivalis, Treponema sp., T. forsythensis, 
P. intermedia and A. actinomycetemcomitans. They also concluded P. intermedia was associated 
with GAgP. In a study red complex bacteria found in that of Generalized CP and GAgP. No 
significant differences found in term of 40 bacteria species in Generalized CP and GAgP [40]. 
Human cytomegalovirus, Epstein–Barr virus type-1 and HSV-1 are also involved in the progres-
sion of the disease [41, 42]. These differences may be related to variations in the societies living 
in the various regions of the world, as well as the difficulties in grouping diseases.
5.2. Host factors
AgP is a disease that shows significant differences from other periodontal diseases in terms 
of severity of destruction, rate of progression, response to treatment, etiologic factors and 
genetic susceptibility criteria. Defects of host defense system and complex factors like micro-
bial flora play a role together in hostility and disease formation affecting severity of destruc-
tion, speed of disease progress and response to treatment. In the response to dental plaque 
accumulation, which leads to gingivitis, substantial evidence has been collected to propose 
large differences between individuals. In line with this concept, it has been shown from the 
initial research attempts on early-onset periodontitis forms that affected individuals, suffer 
from metabolic imbalance or hereditary host response defects.
The first step of periodontal defense is inflammation in innate immune response that pro-
vided a respond to bacterial plaque by neutrophils, macrophages, fibroblasts, epithelial and 
dendritic cells [43]. If this immune response is not capable to control the inflammation pro-
cess, complex inflammatory cascades are activated. Second stage which is called adaptive 
immune response that resumed by antigen-presenting cells and predominantly B-cell lesions 
composed in periodontitis [43]. Tissue destruction in patients with AgP is not directly related 
to bacteria accumulation in root surface. Personal immune response plays a major role in 
severity of destruction [44].
PMNL is an important component of the immune system and found in gingival lesions and in 
root surfaces of AgP cases [45]. Some of neutrophil malfunctions such as increased adhesion, 
reduced chemotaxis, increased superoxide and nitric oxide production and reduced phagocy-
tosis were thought to be responsible for disease progression [46–48]. Hyper-responsive mac-
rophage phenotype including elevated prostaglandin E2 and interleukin-1β levels took place 
among the features of AgP in the 1999 Workshop [49]. According to Kantarci et al. [50] LAgP 
has been associated with various abnormalities of host cell function such as; neutrophil abnor-
malities, reduced chemotaxis, increased superoxide production, reduced receptor expression, 
reduced phagocytosis and killing of A. Actinomycetemcomitans, impaired leukotriene B
4
 and 
signal transduction abnormalities. They suggest the PMNL is not hypofunctional or deficient, 
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but it is hyperfunctional and excessed activity is responsible of the tissue damage. A con-
stantly uncontrolled periodontal infection activates neutrophils and make them more effec-
tively stimulated to counteract microbial episodes. Thus, differences in neutrophil functions 
in AgP are thought to be a combination of genetic and acquired properties of person [51]. 
Human leukocyte antigens (HLA) are antigens that regulate the immune response. HLA-9 
and HLA-15 antigens have been shown to be associated with AgP [8, 52]. Another study has 
shown that HLA class I, HLA class II antigens are associated with periodontal disease [53] 
but no significant associations were found between HLA class II antigens and AgP. There 
is a positive association with HLA-A9 and negative relationship with HLA-A2 and HLA-
B5 have shown in patients with AgP [54]. HLA class II antigens are capable bind peptides 
derived from bacterial antigens and present them to T cells while HLA class I antigens gener-
ally present peptides derived from viruses and self-antigens to cytotoxic T cells. In a theory, 
viral peptide binding and presentation to T cells via HLA-A9 or HLA-B15 is not sufficient for 
activating immune response properly resulting AgP with severe periodontal destruction [53]. 
IgA plays an important role in the host defense system and, locally dominant in saliva. IgA is 
important because of its antiinflammatory function and reduces inflammation by inhibiting 
IgG and IgM production. Studies have shown that the IgA ratio decreases significantly in AgP 
subjects [55]. Hwang et al. provides evidence against the 1999 Workshop’s decision of weak 
serum antibody response in AgP. In their study, serum IgG levels to A. Actinomycetemcomitans 
in GAgP patients is not differ from LAgP, Localized CP and Generalized CP but it is signifi-
cantly increased to several species, including P. gingivalis, T. denticola, and C. rectus [56]. CRP 
is an acute phase response molecule and increases in an inflammatory condition such as heat, 
infection, hypoxia and tissue damage. Elevated fibrinogen levels can activate the inflamma-
tory cascades. Chandy et al. [57] investigated these two molecules in AgP patients. Elevated 
CRP and fibrinogen levels found in CP patients not in AgP and healthy controls. These results 
may explain the severity of the lesions by delaying the immunological response against to 
AgP. In some studies platelet size and function found to decrease in GAgP patients due to the 
consumption of large platelets at sites of periodontal inflammation. Platelets may play active 
role in host response in GAgP patients [58, 59].
5.3. Environmental factors
Environmental factors such as oral hygiene/bacterial plaque, smoking, stress and systemic 
factors may exacerbate the inflammation and play an important role in the periodontitis 
progression. Studies have shown that there is a positive correlation between AgP and stress 
[60]. In a controlled study patients in the GAgP group were significantly more depressed 
and lonely than patients in the CP and control groups [60]. Existing dental plaque is also 
very important to develop the periodontal disease. A positive correlation found between the 
amount of plaque and GAgP, but not in LAgP [61]. Smoking is also a risk factor for AgP [54]. 
In a study smoking found to related disease activity and progression in GAgP but it is not 
associated with LAgP [62]. Also smoking affects the cytokine profiles of patients with AgP 
and disturbs the host–parasite relationship [63]. AgP patients who are smoking showed poor 
clinical respond the periodontal treatment [64].
According to the 1999 workshop, the main feature in diagnosing of AgP is that the individual 
should be medically healthy [1]. However symptoms of the gum in some systemic diseases/
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conditions may resemble AgP. This group of diseases includes; neutropenia, hypophosphata-
sia, leukemias, Cheidak-Higashi syndrome, leukocyte adhesion deficiency, Papillon-Lefevre 
syndrome, trisomy 21, histiocytosis and agranulocytosis [1].
5.4. Genetic factors
AgP is a multifactorial disease and many etiological factors are required for clinical presenta-
tion. Bacterial content and host defense clearly play an important role in the disease. Genetic 
variations may affect the host response to the disease. Once diagnosed, the sibling of the child 
or adolescent must also be investigated for the AgP. The genetic factors that may be involved 
in the pathogenesis of AgP, have been investigated by considering the immune system regu-
lated by genetic factors and that certain genetic polymorphisms may disrupt the defense sys-
tem against the agent that infects the immune system.
Interleukin-1 (IL-1) is a potent pro-inflammatory mediator that is mainly released by mono-
cytes, macrophages and dendritic cells and genetic polymorphisms of IL1 have been studied 
in association with AgP. Three studies have reported no association between the carriage 
rates of the IL1A − 889 (+4845) C → T gene and AgP [65–67], but one study have found an 
association with this gene and AgP in Chinese Population [68]. IL1B + 3954 (+3953) C → T 
gene polymorphisms and carriage rate of the rare (R) allele in Caucasians found associated 
with AgP in a study [65]. In studies involving IL-4 which have anti-inflammatory proper-
ties, no association was found between AgP and genotype encoding this cytokine [69]. In a 
meta-analysis that conducted the evaluating IL-6 polymorphisms, there was concluded an 
associated with AgP and IL-6 polymorphisms [70]. IL-10 is an anti-inflammatory cytokine 
which down-regulates the pro-inflammatory immune response of monocytes and macro-
phages. The results of the studies investigating polymorphism on the gene that encoded IL-10 
were not significant [71, 72]. IL-17 plays an important role in natural and acquired immune 
response; there is a study in mice demonstrating that IL-17 receptor trigger bone loss in infec-
tious conditions [73]. In a recent metaanalysis authors concluded that there is no significant 
association between the polymorphisms rs2275913 and rs763780 in interleukins 17A and 17F 
genes and CP and AgP in the allelic evaluation [74]. IL-23 is a pro-inflammatory cytokine 
and found positively correlated with CP but existing studies how that there is no significant 
association of IL-23 polymorphisms with AgP [75]. IL-8 is a chemokine and plays role of che-
moattractant for the neutrophils. Insufficient studies exist that correlate IL-8 polymorphisms 
with AgP. Existing studies in literature demonstrated that there is no significant association 
between IL-8 polymorphisms and AgP [75].
Tumor necrosis factor (TNF) is a pro-inflammatory cytokine which has the potential to 
stimulate the production of secondary mediators, including chemokines or cyclo-oxygenase 
products, amplifying the degree of inflammation. No associations between the TNFA poly-
morphisms and AgP in a meta-analysis [72]. An Fc receptor is a protein found on the sur-
face of certain cells and part of immunoglobulin (FcγR) link cellular and humoral parts of 
the immune system that contribute to the protective functions of the immune system [76]. A 
Japanese study reported an association for a composite genotype of the Fc cRIIIa N allele and 
the Fc cRIIIb +141 R allele in AgP [77] in contrast in a stud performed with Caucasian popula-
tion there is no association found in term of this gene [78]. There is limited information about 
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polymorphism of FcγR and AgP. The vitamin D receptor was included various biological pro-
cesses such as bone metabolism and the immune response to microbial infections. Nibali et al. 
[79] and Park et al. [80] found an association with AgP but Bret et al. [65] could not find any 
accociation.CD14 and Tolllike receptors (TLRs) are extra and intracellular receptors such as 
recognize pathogen-associated molecules on Gram(+) and Gram(−) bacteria and mediate the 
production of cytokines required for effective immune response. In studies that performed 
to find a relationship CD14 polymorphism and AgP received no association [81, 82]. About 
TLRs, there is limited information and studies are available.
Most studies performed about polymorphisms were limited by sample size and had varia-
tions in case inclusion criteria. Genetic studies can also be limited by geographic and ethnical 
differences. To understand the pathogenesis of this complex disease multicenter studies and 
large sample sizes are required.
6. General treatment strategy
AgP is a complex periodontal disease that causes rapid destruction of the periodonticum and 
even causes tooth loss. Complex pathogens are involved in the etiology of AgP. Therefore, it 
is important for clinicians to treat the disease and maintain periodontal health [83]. The treat-
ment protocols are based on studies so far. Physicians can achieve very effective results if they 
are working with microbial tests during and after treatment. People with the same clinical 
characteristics may have different bacterial flora, or people with different clinical characteris-
tics may have the same bacterial flora. In clinical trials, the success of treatment is assessed by 
considering the probing depth (PD), clinical attachment level (CAL) and bleeding on probing 
(BOP) using conventional periodontal instruments. All parameters for the patients should be 
assessed and the treatment decision should be given. Surgical and non-surgical techniques 
are applied in the treatment of AgP [84]. It is important to treat and obtain frequent controls 
of individuals with AgP which is seen in younger patients coexistent rapid attachment and 
alveolar bone loss. There are studies demonstrated that the post-treatment attachment level 
can be maintained despite the risk of recurrence of the disease [85, 86]. A study of 40-year 
follow-ups from patients with GAgP shows that even the most aggressive and most advanced 
periodontitis cases are treatable [87]. The motivation and adaptation of the patient is very 
important in order to control the disease. In this phase, the patient should be informed by the 
doctor about the role of the patient, the severity of the illness and the risk factors. The main 
purpose of the treatment is to create a clinical condition that can hold the largest number of 
teeth in the mouth for as long as possible. Periodontal treatment is considered in four main 
phases. First phase; initial therapy or non-surgical periodontal treatment. The second peri-
odontal treatment phase is surgical periodontal treatment, third phase prosthetic treatment 
and fourth phase maintenance periodontal treatment.
6.1. Non-surgical treatment of AgP
Removal of agents causing periodontal disease, providing good oral hygiene to the patient, 
and reducing pre-existing gingival inflammation and periodontal pocket depths in advance 
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of future phases are among the goals of non-surgical periodontal treatment. Mechanical treat-
ment involves removal of plaque and its products from dental surfaces (supra/subgingival), 
as well as dental and other plaque-retaining local agents by hand or ultrasonic instruments. 
Root planning are also included. The responses of patients with LAgP to initial periodontal 
care vary in studies. In general, the least amount of work on this issue and it is not long to 
observe the final results. Based on the literature GAgP responds good clinical results to scal-
ing and root planning (SRP) in the short term (up to 6 months). However, after 6 months 
despite frequent visits to the physician and strengthening oral hygiene, relapses and disease 
progression have been reported [88].
Studies have shown that the total supragingival and subgingival plaque mass is reduced by 
mechanical treatment. However, because some pathogens can invade into the tissue, or because 
periodontal instruments are not effective in deep and complex pockets, mechanical treatment 
is sometimes ineffective [89]. The success of periodontal treatment depends on the removal of 
dental plaque and therefore pathogenic microorganisms in the dental plaque. The anti-infective 
treatments applied in this context directly affect the success of the treatment. Anti-infective 
treatment includes both mechanical and chemotherapeutic approaches and aims to destroy or 
reduce the microbial dental plaque biofilm which is primary etiological agent of periodontal 
infections. The use of therapeutic agents especially systemic antibiotics have been widespread 
to be able to obtain predictable treatment responses due to conventional periodontal treatment 
and to support treatment for the specific microbial structure of the disease.
At this time there is a clear consensus that mechanical instrumentation should always precede 
antimicrobial therapy. To achieve effective levels of the drug on the day of the completion of 
SRP [90]. The subgingival bacterial load that will be inhibited by the antimicrobial agent must 
be reduced by mechanical treatment. Insufficient antimicrobial agent concentrations may cause 
the emergence of resistant bacterial strains [88]. The tetracycline group is considered first in 
systemic treatment. Tetracycline and SRP found to be more effective in term of elimination A. 
actinomycetemcomitans, Capnocytophaga and spirochetes comparing only SRP [91]. Tetracycline 
is known to have beneficial effects in wound healing regarding its anticollagenase activity [92] .
Doxycycline is a semisynthetic tetracycline and is effective in the treatment of periodonti-
tis. It is easier to take doxycycline at lower doses and use it with daily foods. In a study 60 
patients were divided into a placebo group and a group that received systemic doxycycline 
(loading dose of 200 mg and doses of 100 mg daily for 14 days) SRP was performed to all 
groups over an 8-week period, systemic antibiotic or placebo was only used during the first 
2 weeks of the SRP. At the end of the study no significant differences were found in term of 
PD, BOP [93]. It was demonstrated in many studies, biofilm showed high levels of resistance 
against tetracycline, minocycline, amoxicillin, doxycycline and amoxicillin/clavulanate. In 
addition, high-degree of antibiotic tolerance has been demonstrated in mature biofilms [94] 
when tetracycline was unable to suppress A. actinomycetemcomitans, it has been raised a com-
bined use of antibiotics for the treatment of AgP. Metronidazole is a nitroimidazole deriva-
tive antibiotic which has a strong bactericidal effect on obligate anaerob Gram(−) bacteria. 
It is highly effective on periodontopathogenic bacteria such as P. gingivalis and P. intermedia 
which in the “red complex” [95]. The combination of 250 mg of metronidazole and 375 mg of 
amoxicillin, three times a day for 7 days, as an adjunct to SRP, was found to be very effective 
Periodontology and Dental Implantology114
in suppressing subgingival A. actinomycetemcomitans load [96]. Guerrero et al. [97] evaluated 
SRP plus systemic metronidazole and amoxicillin in use on clinical parameters, in total of 
41 individuals with GAgP. Twenty randomly selected patients were given 500 mg metroni-
dazole and 500 mg amoxicillin three times a day for 1 week in addition to mechanical treat-
ment, and the remaining 21 patients were given placebo in addition to mechanical treatment. 
Two and six months re-evaluations were made. Additional metronidazole and amoxicillin 
may provide a statistically significant improvement in clinical parameters in the short term. 
Xajigeorgiou et al. [84] investigated metronidazole + amoxicillin, doxycycline, metronidazole 
efficacy in 43 GAgP patient clinically and microbiologically. Patients were randomly divided 
into 4 groups. First group was received SRP plus 500 mg metronidazole +500 mg amoxicillin 
three times a day for 1 week, second group was received 200 mg for the first day loading, 
100 mg doxycycline for the following 14 days, third group was received 500 mg metronida-
zole three times a day for 1 week, and the fourth group was evaluated as the control group. 
After 6 weeks and 6 months patients were reevaluated in term of CAL, BOP, PD. Additional 
metronidazole + amoxicillin or metronidazole plus SRP have been effective comparing the 
other groups. Adjunctive use of metronidazole plus amoxicillin, metronidazole alone or 
clindamycin in patients with GAgP results in well clinical improvements comparing with 
the use of doxycycline for a similar amount of time or with SRP alone [88].
The use of azithromycin in recent years has become an issue in AgP treatment. Long half-life 
of and use of only once every 3 days of azithromycin, provides advantages for the patient and 
the physician. In a study clinical efficacy of the adjunctive use of azithromycin with SRP was 
investigated in AgP. Twelve months after treatment, approximately 1 mm reduction in PD 
and higher percentage of teeth with attachment gain was observed in test group [98]. There is 
no certain protocol for the use of adjunctive systemic antimicrobials with SRP, but in general 
suggests that antibiotic intake should start on the day of debridement completion; debride-
ment should be completed within a short time (preferably <1 week) [94].
Local antibiotic applications may also used to complete the periodontal therapy. Several local 
antibiotic applications have been developed in addition to initial periodontal therapy. These 
include metronidazole, chlorhexidine, minocycline, doxycycline and tetracycline. The use of 
this systems in LAgP may be more beneficial effect in term of the nature of the disease. To 
achieve maximum efficacy, drugs must provide some criteria such as; the drug must reach the 
targeted site of action, remain at an effective concentration and last for an adequate period of 
time [99]. In a study, 26 patients with LAgP divided into a control group, a group receiving 1% 
chlorhexidine gel and a group receiving a 40% tetracycline gel. After 12 weeks, either of these 
antimicrobial agents provide significant additional improvement of the clinical parameters 
[100]. Kaner et al. compared local chlorhexidine chip and ministration and systemic amoxi-
cillin plus metronidazole combination in addition to SRP on clinical parameters in GAgP 
patients. Systemic use of amoxicillin plus metronidazole combination found to be statistically 
significant clinical improvements comparing the local chlorhexidine chip [101]. In a similar 
study Purucker et al. [102] concluded that additional applied local (tetracycline fibers) and 
systemic (500 mg amoxicillin/clavulanic acid) antibiotics showed equally benefits in terms of 
clinical parameters. In conclusion, local antimicrobial adjuvant effects reported in the litera-
ture do not appear to improve on the adjunctive effect of systemic antibiotics in patients with 
AgP. When using such systems, cost-benefit and efficiency should be considered well.
Aggressive Periodontitis
http://dx.doi.org/10.5772/intechopen.76878
115
6.2. Surgical treatment of AgP
Surgical treatment may require for the remaining pockets after initial periodontal treatment 
of AgP. The surgical approach has the advantages such as; reaching difficult anatomical for-
mations of the teeth, cleaning the pocket epithelium from invaded A. actinomycetemcomitans 
and application of regenerative procedures.
Twenty-five periodontal lesions in seven patients with LAgP divided into three treatment 
groups: SRP; SRP plus soft tissue curettage; SRP plus modified Widman flap surgery. The 
microbiologic and clinical measurements were performed up to 16 weeks. At the end of 
the study SRP alone unable to suppress A. actinomycetemcomitans in periodontal lesions, in 
contrast SRP plus soft tissue curettage and modified Widman flap surgery succeeded [103]. 
Systemic antibiotic use can preferred with various surgical techniques in the treatment of 
AgP. Kornman and Robertson [104] found modified Widman flap surgery plus tetracycline 
was effective in areas where the black pigmented bacteroides and A. actinomycetemcomitans 
load was high. Lindhe and Liljenberg [105] treated 16 patients with modified Widman flAgP 
surgery plus tetracycline (14 days). As a result of 5-year follow-up, successful clinical results 
were obtained and radiological bone fill in angular bony defects. In a case series performed by 
Buchmann et al. [106], SRP and modified Widman flap surgery plus systemic amoxicillin/met-
ronidazole combination provide periodontal tissue stabilization at a rate 95% over 5 years.
There are many methods to regain bone in vertical bone defects such as bone grafting, guided 
tissue regeneration by using membranes, the use of biologic modifiers and combinations of 
the above. Autografts are the gold standard and have been extensively used because of its 
osseoinductive, osseoconductive, and osteogenic properties but it has limitations like mor-
bidity and mortality hence different graft materials are available in practice. Allografts (e.g. 
freeze-dried bone allograft), xenografts (bovine or corral derived) and alloplastic materials 
(e.g. bioactive glass, hydroxyapatite and beta-tricalcium phosphate) are alternatively used 
instead of autograft [107]. Yukna and Sepe [108] demonstrated an average defect fill (80%) in 
12 LAgP patients using freeze-dried bone allografts. In a study different graft materials were 
evaluated in 10 patients with LAgP. 4:1 ratio combination of beta-tricalcium phosphate/tetra-
cycline, hydroxyapatite/tetracycline or freeze-dried bone allograft/tetracycline were applied 
into these groups. Each graft material showed a decrease in defect and pocket depth although 
no significant differences between the different grafting materials were found in terms of 
hard-tissue or soft-tissue changes. But hydroxyapatite/tetracycline showed a greater percent-
age of defect fill was comparing with beta-tricalcium phosphate/tetracycline [109].
Membranes have been grouped into two major categories: nonresorbable (high-density 
polytetrafluoroethylene (PTFE) membranes reinforced or not with a titanium framework (e.g. 
Cytoplast ® TXT-200; Osteogenics Biomedical, Lubbock, Tex., USA) and resorbable mem-
branes (polylactic acid (PLA) and its copolymers, tissue-derived collagen membranes) [110]. 
Nonresorbable membranes serve as a space maintenance which is needed for tissue regenera-
tion and inert also biocompatible. Unfortunately, second surgery for removal or membrane 
exposure take place among its disadvantages. Although resorbable membranes show lack of 
sufficient strength, unpredictable degradation rate and cause a greater inflammatory response 
[110]. Usage of nonresorbable or resorbable membranes for treating intrabony defects in AgP 
has been shown to be effective in many studies [86, 111].
Periodontology and Dental Implantology116
6.3. Other treatment modalities
Photodynamic antimicrobial therapy that photosensitizers (toluidine blue, methylene blue, 
malachite green) are used inside periodontal pockets for increasing the cytotoxic potential of 
laser light to potential periodontal pathogens. In a metaanalysis authors concluded that pho-
todynamic antimicrobial therapy cannot be suggested as routine with nonsurgical treatment 
of patients with AgP according to lack of evidence based on the literature [112].
Enamel matrix proteins (amelogenin) which provides new cementum and the formation 
of new attachment in periodontal defects and growth factors/differentiation factors (plate-
let-derived growth factor, insulin-like growth factor, fibroblast growth factor, bone mor-
phogenetic protein, transforming growth factor-beta) which play an import role in tissue 
development and healing are tools for gaining attachment. Their effectiveness on periodon-
tium were demonstrated in many studies with CP but studies with AgP, mostly exist as case 
reports [113, 114]. Yılmaz et al. [115] treated patients with GAgP with a total of 12 intrabony 
defects with the combination of platelet rich plasma +bovine derived xenograft combination. 
PD, marginal recession, relative attachment, probing bone and radiographic bone levels were 
measured at the beginning and at 12 months reentry. The researchers noted that the combina-
tion of platelet rich plasma and bovine derived xenograft for the treatment of GAgP, provided 
successful clinical results in large intrabony defects and that prognosis was affected positively 
even for teeth that were thought to have hopeless prognosis.
Dental implants are a widely used treatment edentulism and provides functional and esthetic 
resolutions. Since tooth loss is frequently seen in AgP patients, dental implant applications 
can be applied. However, marginal bone loss and implant survival rates in AgP patients sig-
nificantly higher than those of CP and healthy subjects [113, 114]. Care should be taken when 
considering dental implant in AgP patients. Frequent follow-ups should not be neglected in 
these patients.
6.4. Maintenance therapy
After the treatment performed and provided the health of periodontal tissues, patient should 
be included in the maintenance program. Due to the recurrence nature of AgP, maintenance 
is given to for prevention of additional tooth loss and disease recurrence. Regular controls 
are useful for controlling the progression of the disease. These controls should be lifelong, 
but there is no definitive protocol for frequency. Some researchers suggested monthly checks 
during the first 6 months after the treatment finished. Some researchers stated that 3–4 con-
trols per year would suffice. In every control session; PD and CAL should be assessed. Also, 
when necessary, SRP should be performed. Radiographs should be taken separately from 
each tooth or area affected by the disease once a year. Local antibiotic administration may 
be preferred to risky areas [116]. The prognosis of teeth that affected AgP depends on many 
factors such as the amount of missing bone, the presence or absence of furcation region, the 
morphology of bone defects, the degree of mobility, crown/root ratio, occlusal contacts, oral 
hygiene and general health. Treatment should be evaluated according to the initial condition. 
It is also important to perform microbial testing at every control session whenever possible. 
Thus, the physician may be an idea about the activation of the disease.
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7. Conclusion
AgP is a complex disease and has multifactorial etiology. While bacterial plaque is essen-
tial for initiation of disease, it is generally accepted that genetic factors and host immune 
response play a large role in the disease susceptibility. Also environmental and behavioral 
factors determine the final clinical outcome. The outcome of rapid and severe alveolar bone 
loss; gingival recession, pathological migration of teeth, mobility and eventual loss of teeth 
occur. Because of the clinical results, AgP patients suffer social problems due to esthetic, pho-
netic and nutritional problems and their quality of life diminishes. The treatment of these 
patients is quite challenging, due to the absence of a standard treatment protocol for this 
disease which its etiology is not fully understood, but also because of the rapid progression, 
severe periodontal tissue loss and recurrence of the disease. Non-surgical and surgical peri-
odontal treatments combined with systemic antibiotics are recommended for the complete 
eradication of deep periodontal pockets. In long term, active periodontal treatment must fol-
lowed by maintenance periodontal treatment for preventing attachment and tooth loss.
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